RETA News

Five IPOs raised $1.5 billion as the year's biggest week concluded the year's biggest month of IPO activity - further evidence that the IPO market's rebound is underway. Three were IPOs of profitable LBO'd companies, bringing the 2016 total up to six. While the tech sector has remained largely absent, high-growth venture-backed software provider Twilio (TWLO)...read more

Four IPOs began trading on Thursday after raising $1.5 billion, marking the IPO market's biggest day, week and month of 2016 based on number of deals and proceeds raised. The 31 deals year-to-date have raised $5.4 billion, down about 55% from last year on both measures, and have an average first-day pop of 4% and total return of 19%. In May, 15 deals priced, up from just 8 in April,...read more

Reata Pharmaceuticals, which is developing therapies for life-threatening forms of pulmonary hypertension, raised $60.5 million by offering 5.5 million shares at $11. It had originally planned to raise $60 million by offering 4.0 million shares at a range of $14 to $16. Reata Pharmaceuticals plans to list on the Nasdaq under the symbol RETA. Citi, Cowen & Company and Piper...read more

The year's most active week by deal count and proceeds is set to cap off the year's busiest month: The six scheduled IPOs would bring May's IPO count up to 16, making it the busiest month since...read more